Fidelity Advisor Biotechnology Fund ALNY Holdings History
Fidelity Advisor Biotechnology Fund's Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 304,886.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $80.26 Mil. This investment constitutes 5.91% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.23% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q4. And since then Fidelity Advisor Biotechnology Fund has made 5 purchases of ALNY, at an average price of $117.71, for a total of 1.23 Mil shares. In addition, there have been 9 sales at an average price of $190.48 for 922,600.00 shares. Based on historical transaction data and ALNY's current price of $320.52, Fidelity Advisor Biotechnology Fund's estimated gain on his ALNY holdings is $128.98 Mil, reflecting a 89.27% gain to date.
Fidelity Advisor Biotechnology Fund ALNY ($320.52) Holding Chart
Fidelity Advisor Biotechnology Fund ALNY ($320.52) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
